[EN] SOMATOSTATIN RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USING THE SAME<br/>[FR] COMPOSÉS ANTAGONISTES DU RÉCEPTEUR DE LA SOMATOSTATINE ET PROCÉDÉS D'UTILISATION ASSOCIÉS
申请人:CDRD VENTURES INC
公开号:WO2017136943A1
公开(公告)日:2017-08-17
The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I, compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
Somatostatin receptor antagonist compounds and methods of using the same
申请人:CDRD VENTURES INC.
公开号:US11279732B2
公开(公告)日:2022-03-22
The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I, compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
本发明涉及具有式 I 结构的体生长抑素受体拮抗剂化合物、包含这些化合物的组合物以及使用这些化合物和组合物的方法。这些化合物可用于预防或治疗低血糖症。
SOMATOSTATIN RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USING THE SAME
申请人:CDRD VENTURES INC.
公开号:US20190040102A1
公开(公告)日:2019-02-07
The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I, compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
Vigorita; Saporito; Pizzimenti, Farmaco, Edizione Scientifica, 1984, vol. 39, # 6, p. 514 - 523